634
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The Potential Importance of Paraoxonase-1 in Surgical Patients

&

References

  • Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109–117.
  • Bojic S, Kotur-Stevuljevic J, Kalezic N, et al. Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis. Dis Markers.2014;2014:1. doi:10.1155/2014/427378.
  • Mackness M, Mackness B. Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015;567(1):12–21. doi:10.1016/j.gene.2015.04.088.
  • Kotur-Stevuljevic J, Spasic S, Stefanovic A, et al. Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population. Clin Chem Lab Med. 2006;44(10):1206–1213.
  • Kotur-Stevuljevic J, Bogavac-Stanojevic N, Jelic-Ivanovic Z, et al. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients. Atherosclerosis. 2015;241(1):192–198. doi:10.1016/j.atherosclerosis.2015.05.016.
  • Kotur-Stevuljevic J, Spasic S, Jelic-Ivanovic Z, et al. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin Biochem. 2008;41(13):1067–1073. doi:10.1016/j.clinbiochem.2008.06.009.
  • Iftimie S, Escribano A, Díez-Sans A, et al. Influence of surgical procedures on serum paraoxonase-1-related variables and markers of inflammation in hospitalized patients. J Invest Surg. 2021;34(2):216–224.
  • Rizzo M, Berneis K, Zeljkovic A, Vekic J. Should we routinely measure low-density and high-density lipoprotein subclasses? Clin Lab. 2009;55(11–12):421–429.
  • Vukicevic P, Mikic A, Kotur-Stevuljevic J, et al. Oxidative stress andplatelet activation during on-pump and off-pump coronary artery bypass grafting in patients withdouble grafted vessels. Biotechnol Biotechnol Equip. 2016;30:1132–1141. doi:10.1080/13102818.2016.1217168.
  • Rosenson RS, Brewer HB Jr, Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48–60. doi:10.1038/nrcardio.2015.124.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.